Organo-tricyanoborates as tectons: illustrative coordination polymers based on copper(I) derivatives

The first systematic study on the use of tricyanoborates as ligands is presented. The tricyanoborates [RB(CN)3]- (R = oct and Ph) can be prepared by direct cyanation of RBCl2 precursors as well as by thermolysis of the corresponding isocyanides [RB(NC)3]-. The first organo-cyanogallates [RGa(CN)3]- (R = Bu, C6H2-2,4,6-Me3) were prepared from the corresponding dichloride, the structure of Et4N[mesGa(CN3] being confirmed crystallographically. The reaction of equimolar [RB(CN)3]- (R = oct, Ph) and [Cu(MeCN)4]+ afforded two-dimensional polymers [RB(CN)3Cu(NCMe)]. The sheets arise via conjoined hexagonal B3Cu3(CN)6 rings with chair conformations. The reaction of excess [PhB(CN)3]- and [Cu(MeCN)4]+ gives the polymer [K(18-crown-6)]{Cu[PhB(CN)3]2}. Treatment of [PhB(CN)3]- with [Cu(PCy3)2(NCMe)x]PF6 gave the one-dimensional polymer [PhB(CN)3Cu(PCy3)2], wherein two of the three BCN substituents are coordinated.     

Potent and selective structure-based dibenzofuran inhibitors of transthyretin amyloidogenesis: kinetic stabilization of the native state

Transthyretin (TTR) amyloidogenesis requires rate-limiting tetramer dissociation and partial monomer denaturation to produce a misassembly competent species. This process has been followed by turbidity to identify transthyretin amyloidogenesis inhibitors including dibenzofuran-4,6-dicarboxylic acid (1). An X-ray cocrystal structure of TTR.1(2) reveals that it only utilizes the outer portion of the two thyroxine binding pockets to bind to and inhibit TTR amyloidogenesis. Herein, structure-based design was employed to append aryl substituents at C1 of the dibenzofuran ring to complement the unused inner portion of the thyroxine binding pockets. Twenty-eight amyloidogenesis inhibitors of increased potency and dramatically increased plasma TTR binding selectivity resulted. These function by imposing kinetic stabilization on the native tetrameric structure of TTR, creating a barrier that is insurmountable under physiological conditions. Since kinetic stabilization of the TTR native state by interallelic trans suppression is known to ameliorate disease, there is reason to be optimistic that the dibenzofuran-based inhibitors will do the same. Preventing the onset of amyloidogenesis is the most conservative strategy to intervene clinically, as it remains unclear which of the TTR misassembly intermediates results in toxicity. The exceptional binding selectivity enables these inhibitors to occupy the thyroxine binding site(s) in a complex biological fluid such as blood plasma, required for inhibition of amyloidogenesis in humans. It is now established that the dibenzofuran-based amyloidogenesis inhibitors have high selectivity, affinity, and efficacy and are thus excellent candidates for further pharmacologic evaluation.     

P-C Bond formation via direct and three-component conjugate addition catalyzed by 1,5,7-triazabicyclo[4.4.0]dec-5-ene (TBD)

The direct addition of P(O)-H bonds (dialkyl phosphites and diphenyl phosphonite) across various activated alkenes was catalyzed effectively by 1,5,7-triazabicyclo[4.4.0]dec-5-ene (TBD). This is a mild, rapid and efficient protocol to generate P-C bonds. This simple procedure allows a series of dialkyl alkylphosphonates and trisubstituted phosphine oxides to be prepared in high yields. Further investigation resulted in a convenient one-pot, three-component reaction containing diphenyl phosphonite, malononitrile and an aldehyde.     

Copper(II)-catalyzed aerobic oxidation of primary alcohols to aldehydes in ionic liquid [bmpy]PF6

A room-temperature aerobic oxidation of primary alcohols to aldehydes catalyzed by the three-component system acetamido-TEMPO/Cu(ClO(4))(2)/DMAP in the ionic liquid [bmpy]PF(6) has been developed, and the catalysts can be recycled and reused for five runs without any significant loss of catalytic activity. [reaction: see text]